Cell Therapy Advances but Parkinson's Research Still on Shaky Ground
This article was originally published in Start Up
Executive Summary
A trio of recent papers provides encouragement about the use of cell therapy to treat motor symptoms in Parkinson's disease. But the discussions also highlight how much is not known about the origins of Parkinson's disease, and suggest there may be fundamental limitations to any therapy strategy based on restoring dopamine--be it through implanting dopamine neurons or via existing drugs.